The shoulder’s hidden alarm: metastatic uterine leiomyosarcoma in disguise
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20260206Keywords:
Uterine leiomyosarcoma , Metastasis, Palliative care, AtypicalAbstract
Uterine Leiomyosarcoma is a rare but aggressive soft tissue tumour arising from smooth muscle fibres of the uterus. Leiomyosarcoma is one of the most common types of smooth muscle-derived malignancies in uterus and it is an aggressive malignancy. We are reporting a unique case of a 54-year-old woman who presented with uterine leiomyosarcoma along with humeral metastasis manifesting as a right shoulder swelling, an uncommon site of metastasis. This case report emphasizes the rarity of this presentation and underscores the importance of thorough clinical and radiological evaluations in atypical presentations. This patient also had a significant symptom relief and improvement in quality of life following palliative care and chemotherapy.
Metrics
References
Mestiri S, Elghali MA, Bourigua R, Abdessayed N, Nasri S, Amine BA, et al. Soft tissue leiomyosarcoma-diagnostics, management, and prognosis. 2019;2036361318820171.
Bathan AJ, Constantinidou A, Pollack SM, Jones RL. Diagnosis, prognosis, and management of leiomyosarcoma. Curr Opin Oncol. 2013;25(4):384–9. DOI: https://doi.org/10.1097/CCO.0b013e3283622c77
Society of Gynecologic Oncology. sentinel articles in gynecologic cancer.2023.
Coindre JM, Terrier P, Guillou L, Le Doussal V, Collin F, Ranchère D, et al. Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas. Cancer. 2001;91(10):1914–26. DOI: https://doi.org/10.1002/1097-0142(20010515)91:10<1914::AID-CNCR1214>3.0.CO;2-3
Tirumani SH, Deaver P, Shinagare AB, Tirumani H, Hornick JL, George S, et al. Metastatic pattern of uterine leiomyosarcoma: retrospective analysis of the predictors and outcome in 113 patients. J Gynecol Oncol. 2014;25(4):306–12. DOI: https://doi.org/10.3802/jgo.2014.25.4.306
Garcia, L. Leiomyosarcoma: 7 facts about this rare soft tissue cancer. MD Anderson Cancer Center. Available at: https://www.mdanderson.org/cancerwise/ leiomyosarcoma--7-facts-about-this-rare-soft-tissue-cancer.h00-159536589.html.Accessed on 26 October 2025.
Byar KL, Fredericks T. Uterine Leiomyosarcoma. J Adv Pract Oncol. 2022;13(1):70–6. DOI: https://doi.org/10.6004/jadpro.2022.13.1.6
Menon G, Mangla A, Yadav U. Leiomyosarcoma. In: Stat Pearls Publishing. 2024.
Yildirim Y, Inal MM, Sanci M, Yildirim YK, Mit T, Polat M, et al. Development of uterine sarcoma after tamoxifen treatment for breast cancer: report of four cases. Int J gynecol cancer. 2005;15(6):1239–42. DOI: https://doi.org/10.1111/j.1525-1438.2005.00170.x
Paudel P, Dhungana B, Shrestha E, Verma D. Leiomyosarcoma of the Uterus: A Rare Diagnosis. Cureus. 2021;13(8):e17418. DOI: https://doi.org/10.7759/cureus.17418
Uterine Sarcoma Treatment (PDQ®)–Patient Version. - National Cancer Institute. Available at: www.cancer.gov. Accessed on 26 October 2025.
LiBrizzi CL, Vankara A, Meyer CF, Levin AS, Morris CD. Bone metastases in patients with leiomyosarcoma: a retrospective analysis of survival and surgical management. Sarcoma. 2022;2022:6806932. DOI: https://doi.org/10.1155/2022/6806932
Hensley ML, Wathen JK, Maki RG, Araujo DM, Sutton G, Priebat DA,et al. Adjuvant therapy for high-grade, uterus-limited leiomyosarcoma: results of a phase 2 trial (SARC 005). Cancer. 2013;119(8):1555-61. DOI: https://doi.org/10.1002/cncr.27942
Kelley TW, Borden EC, Goldblum JR. Estrogen and progesterone receptor expression in uterine and extrauterine leiomyosarcomas: an immunohistochemical study. Morphol. 2004 ;12(4):338-41. DOI: https://doi.org/10.1097/00129039-200412000-00008
Downloads
Published
How to Cite
Issue
Section
